HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kayhan A Tayarani-Binazir Selected Research

Benserazide

4/2012Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
6/2010The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
4/2007Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kayhan A Tayarani-Binazir Research Topics

Disease

6Parkinson Disease (Parkinson's Disease)
10/2013 - 04/2007
3Dyskinesias (Dyskinesia)
06/2010 - 04/2007

Drug/Important Bio-Agent (IBA)

6Levodopa (L Dopa)FDA LinkGeneric
10/2013 - 04/2007
3BenserazideIBA
04/2012 - 04/2007
2Oxidopamine (6 Hydroxydopamine)IBA
10/2013 - 09/2010
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2010 - 04/2007
1Aromatic Amino Acids (Aromatic Amino Acid)IBA
04/2012
1ProdrugsIBA
09/2010
1Carbidopa (Lodosyn)FDA LinkGeneric
06/2010
1Dopa DecarboxylaseIBA
06/2010
1Dopamine Agonists (Dopamine Agonist)IBA
02/2010
1pramipexol (pramipexole)FDA LinkGeneric
02/2010
1glycine amideIBA
04/2007
1NeuropeptidesIBA
04/2007